Orlaskin Hydrating Sunscreen
Generic Name: orlaskin hydrating sunscreen
Brand Names:
Orlaskin Hydrating Sunscreen
sunscreen
Overview
sunscreen
Uses
Uses Helps prevent sunburn. If used as directed with other sun protection measures ( see directions ), decreases the risk of skin cancer and early skin ageing caused by the sun.
Dosage
Directions Shake the spray bottle well before use. Hold the spray bottle at an appropriate distance from the face and neck . Spray evenly onto the entire face and neck area. Avoid direct contact with eves . In case of eye contact , rinse immediately with water. For continued sun protection , reapply every 2 hours
Warnings
Warnings For external use only. Avoid contact with eyes , wear protective clothing , hats and eyewear when exposed to the sun . Avoid prolonged exposure in the sun. Keep out of reach of children. Do not use on damaged or brokenskin. Store in a cool , dry place and avoiddirect sunlight. If using with other sun protection products , consult with a doctor before use. Do not use on damaged or broken skin
Storage
Other information Protect the product in this container from excessive heat and direct sun
Frequently Asked Questions
What is Orlaskin Hydrating Sunscreen used for?▼
Uses Helps prevent sunburn. If used as directed with other sun protection measures ( see directions ), decreases the risk of skin cancer and early skin ageing caused by the sun.
What are the important warnings for Orlaskin Hydrating Sunscreen?▼
Warnings For external use only. Avoid contact with eyes , wear protective clothing , hats and eyewear when exposed to the sun . Avoid prolonged exposure in the sun. Keep out of reach of children. Do not use on damaged or brokenskin. Store in a cool , dry place and avoiddirect sunlight. If using with other sun protection products , consult with a doctor before use. Do not use on damaged or broken skin
Related Medications
Pvp K30
pvp k30
Dosage form: POWDER. Active ingredients: N-VINYLPYRROLIDINE (1 g/g). Category: BULK INGREDIENT.
Calcarea Caustica
calcarea caustica
Dipyridamole
dipyridamole
Platelet Aggregation Inhibitor [EPC]
Dipyridamole is a coronary vasodilator described as 2,6 bis-(diethanolamino)-4,8 dipiperidino-pyrimido-(5,4-d) pyrimidine. The structural formula is: C24H40N8O4 MW 504.63 Dipyridamole Injection, USP is a sterile, odorless, pale yellow liquid which can be diluted in sodium chloride injection or dextrose injection for intravenous administration. Each mL contains 5 mg dipyridamole, USP, 50 mg polyethylene glycol 600 and 2 mg tartaric acid in Water for Injection, USP.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.